Basic Information
SeraNovo has a rich technical platform in formulation development, which can enhance intestinal solubility and drug bioavailability. SeraNovo specializes in the development of oral formulations for poorly soluble drugs and has invented the Deep Eutectic Solvent platform technology, signing its first licensing agreement in October 2019.
SeraNovo B.V.
Netherlands
less than 15 people
January 01, 2017
info@seranovo.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios